RAPT Therapeutics Inc.

NASDAQ: RAPT · Real-Time Price · USD
11.79
0.54 (4.80%)
At close: Aug 15, 2025, 3:59 PM
11.65
-1.18%
After-hours: Aug 15, 2025, 06:13 PM EDT

RAPT Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-129.87M -116.8M -83.84M -69.2M
Depreciation & Amortization
1.2M 1.22M 1.05M 996K
Stock-Based Compensation
19.93M 17.09M 11.26M 9.95M
Other Working Capital
34.37M -1.84M -5.04M -5.23M
Other Non-Cash Items
-477K -4.06M 2.09M 1.53M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
25.91M 5.5M -1.33M -4.3M
Operating Cash Flow
-83.3M -97.05M -70.77M -61.03M
Capital Expenditures
-122K -1.13M -845K -755K
Cash Acquisitions
n/a n/a 44.65M 80.59M
Purchase of Investments
-82.22M -161.5M -190.86M -164.98M
Sales Maturities Of Investments
135.04M 266.75M 146.21M 84.39M
Other Investing Acitivies
n/a n/a -44.65M -80.59M
Investing Cash Flow
52.7M 104.13M -45.49M -81.35M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.45M 1.39M 2.02M
Financial Cash Flow
152.85M 1.45M 131.18M 141.48M
Net Cash Flow
122.26M 8.53M 14.92M -891K
Free Cash Flow
-83.42M -98.17M -71.62M -61.78M